home / stock / bicx / bicx news

BICX News and Press, BioCorRx Inc. From 08/16/22

Stock Information
Company Name: BioCorRx Inc.
Stock Symbol: BICX
Market: OTC
Website: biocorrx.com
Menu
BICX BICX Quote BICX Short BICX News BICX Articles BICX Message Board
Get BICX Alerts

News, Short Squeeze, Breakout and More Instantly...
BICX - BioCorRx Provides Business Update for the Second Quarter of 2022

ANAHEIM, CA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the second qu...
BICX - BioCorRx to Participate in the Benzinga All Access Event on July 15th

ANAHEIM, CA, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Brady Granier, President and...

BICX - BioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - July 6, 2022) - The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX) ("the Company"), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. CEO and CFO of the Company, Lourdes...

BICX - BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA - ( NewMediaWire ) - June 30, 2022 -  BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the first subject has been dosed in the Phase I cl...
BICX - BioCorRx Featured on LiveNOW from FOX

ANAHEIM, CA - ( NewMediaWire ) - June 17, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Tom Welch, Executive Vice President of BioCorRx Inc., was feat...

BICX - Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)

The addiction treatment space has been pummeled along with everything else in the growth side of the stock market so far in 2022. For long-term investors, this could represent a huge gift, especially as some of the stocks in this space are also working in new domains and technologies, includi...

BICX - Small Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)

The addiction treatment space has been pummeled along with everything else in the growth side of the stock market so far in 2022. For long-term investors, this could represent a huge gift, especially as some of the stocks in this space are also working in new domains and technologies, includi...
BICX - BioCorRx to Present at the LD Micro Invitational XII on June 7th

ANAHEIM, CA - ( NewMediaWire ) - May 31, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, Chief Executive Officer, Chief Financial Offi...

BICX - BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

Collaboration to create a synergistic treatment offering, combining BioCorRx’s MAT treatment program and 2B3D virtual reality technology Plans toward expanding the offering to other at-risk groups upon evaluating results of pilot with veterans ANAHEIM, CA - ( NewMediaWire ) - ...

BICX - BioCorRx GAAP EPS of -$0.14, revenue of $0.02M

BioCorRx press release (OTCQB:BICX): Q1 GAAP EPS of -$0.14. Revenue of $0.02M (+100.0% Y/Y). For further details see: BioCorRx GAAP EPS of -$0.14, revenue of $0.02M

Previous 10 Next 10